☆ 4.6 Article

Oral anticoagulant switching in patients with atrial fibrillation: a scoping review

BMJ OPEN (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients

Thane Feldeisen et al.

Summary: The majority of patients on oral anticoagulant therapy, whether warfarin or DOACs, continued anticoagulation treatment following a bleeding event. Most patients opted to restart their previous anticoagulation therapy, with a majority choosing the same type of anticoagulant they were previously taking.

JOURNAL OF PHARMACY PRACTICE (2023)

添加到收藏夹

Review Medicine, Research & Experimental

Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review

Stefano Ballestri et al.

Summary: This article systematically evaluates the risk of bleeding complications of direct oral anticoagulants (DOACs) compared to vitamin K antagonists (VKAs) in patients with atrial fibrillation and venous thromboembolism. It also discusses the management of bleeding complications and the possibility of resuming anticoagulation for special patient populations. Recommendations for choosing the optimal DOAC to minimize adverse events according to individual patient characteristics and bleeding risk are provided.

ADVANCES IN THERAPY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA

Amol D. Dhamane et al.

Summary: The study compared the risk of persistence with oral anticoagulants among patients with non-valvular atrial fibrillation (NVAF). The results showed differences in medication persistence across different OAC agents, even after accounting for clinical events. It is important for clinicians and patients to consider these differences, as non-persistence to OAC therapy is associated with thromboembolic complications.

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2022)

添加到收藏夹

Article Hematology

Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

Myrthe M. A. Toorop et al.

Summary: NVAF patients with low pre-switch TTR had a worse persistence pattern to DOAC after switching from VKA compared to those with high pre-switch TTR.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Switching of oral anticoagulants in patients with nonvalvular atrial fibrillation: A narrative review

Adane Teshome Kefale et al.

Summary: Switching among oral anticoagulants is common in clinical practice, often related to safety concerns, poor anticoagulation control, and ease of use. Limited studies on reasons for switching and clinical outcomes show inconsistent results, requiring further prospective research to better understand potential rationales for switching and its impact.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk

Joris J. Komen et al.

Summary: The study aimed to investigate long-term adherence and persistence with non-vitamin K oral anticoagulant (NOAC) treatment in atrial fibrillation patients. Results showed that while persistence rates decreased over time, persistent patients exhibited high adherence rates. Both non-persistence and poor adherence were associated with an increased risk of stroke.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Melissa E. Middeldorp et al.

Summary: The study aimed to assess the rate, causes, and predictors of cessation of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation. The results indicated that NOAC use is safe and well-tolerated in a real-world setting, with age and gender being potential independent predictors of NOAC cessation. Further research is needed to determine if apixaban is better tolerated compared to other NOACs.

HEART (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

One-year Follow-up Results of the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry

Yutao Guo et al.

Summary: The ChiOTEAF registry presents contemporary data on AF management in elderly Chinese patients, highlighting the need for multiple comorbidities management due to poor adherence to NOACs and common use of antiplatelet therapy in this high-risk population.

JOURNAL OF ARRHYTHMIA (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Initiator Types and the Causal Question of the Prevalent New-User Design: A Simulation Study

Michael Webster-Clark et al.

Summary: The new-user design focusing on treatment initiators reduces confounding factors but may result in smaller study sizes and reduced external validity. Previous research has suggested using time-conditional propensity-score matching to mitigate prevalent user bias.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis

Madeleine Durand et al.

Summary: The study found that apixaban is associated with lower risks of stroke and bleeding compared with rivaroxaban, and similar risks compared with dabigatran.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Switching between direct oral anticoagulants: a systematic review and meta-analysis

Michele Romoli et al.

Summary: The study found that apixaban may carry a lower risk of DOAC-to-DOAC switch compared to dabigatran and rivaroxaban. Further research is needed to confirm the long-term safety and effectiveness of this switching paradigm.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study

Benjamin N. Rome et al.

Summary: This study found that higher copayments in commercial insurance for NOACs were associated with lower adherence and higher rates of discontinuation in the first year among newly initiating atrial fibrillation patients. Policies to lower or limit cost sharing of important medications may lead to improved adherence and better outcomes among patients receiving NOACs.

AMERICAN HEART JOURNAL (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin

Krishna N. Pundi et al.

Summary: The study found that in atrial fibrillation patients switched from warfarin to DOAC, most were able to achieve adequate DOAC adherence despite low pre-switch TTRs. However, TTR trajectories remained low in non-switchers. Patients with low warfarin TTR more consistently achieved treatment targets after switching to DOACs, although adherence-oriented interventions may be beneficial.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015)

M. Sabate et al.

Summary: This study described and compared the adherence to different direct oral anticoagulants (DOACs) in eight European databases representing six countries. Despite differences in database characteristics and population demographics, a similar pattern was observed with apixaban having the highest persistence and dabigatran having the highest rates of discontinuation and switching at 12 months in most databases.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study

Shadi Yaghi et al.

Summary: Despite receiving anticoagulation therapy, atrial fibrillation patients who suffer from ischemic stroke may still have a higher risk of recurrent ischemic events. Switching anticoagulant classes does not reduce the risk of recurrent ischemic events or symptomatic intracranial hemorrhage.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy

Nijole Bernaitis et al.

Summary: This study found that when patients with atrial fibrillation were switched from warfarin to a non-vitamin K oral anticoagulant (NOAC), the potential for pharmacokinetic (PK) drug interactions significantly reduced but remained around 40%. Identifying and managing potential PK drug interactions with NOACs remains a priority to optimize the clinical benefit of these anticoagulants.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial Fibrillation

Woldesellassie M. Bezabhe et al.

Summary: The study showed that over the past 10 years, the proportion of high stroke risk patients with atrial fibrillation prescribed oral anticoagulants increased by one-third, with significant variation in prescribing patterns observed between different general practices.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study

Anneka Mitchell et al.

Summary: The study found a significant increase in the prescribing of oral anticoagulants for atrial fibrillation patients aged 75 years and older, but disparities still exist based on age and comorbidities. Elderly patients and those with comorbidities such as dementia, history of falls, major bleeds, and fractures were less likely to be prescribed oral anticoagulants.

BMC MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries

Joris J. Komen et al.

Summary: The study found high persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment among atrial fibrillation patients in five Western European healthcare settings, with an increasing trend over the years. Dabigatran showed slightly lower persistence and adherence compared to other NOAC medications.

EUROPACE (2021)

添加到收藏夹

Article Hematology

5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC Registry

Luise Tittl et al.

Summary: This study provided reassuring long-term outcome data for atrial fibrillation patients receiving rivaroxaban treatment, showing low rates of fatal thromboembolic and bleeding complications over a 5-year follow-up period.

THROMBOSIS RESEARCH (2021)

添加到收藏夹

Review Medicine, General & Internal

Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation

Giovanni Luca Botto et al.

Summary: NOACs are the preferred choice for preventing AF-related stroke and systemic embolism, even when TTR >70% there are reasons to consider switching from VKAs to NOACs. NOACs have a lower risk of intracranial hemorrhage compared to VKAs and provide protection against renal function and cardiovascular events.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Health Care Sciences & Services

Updated methodological guidance for the conduct of scoping reviews

Micah D. J. Peters et al.

Summary: This paper describes the updated methodological guidance for conducting a JBI scoping review and the development of the PRISMA-ScR. The updated guidance includes additional information on methodological issues and aligns with the PRISMA-ScR for consistent reporting. Ongoing methodological projects are planned to further refine the methodology.

JBI EVIDENCE IMPLEMENTATION (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients

Steven Deitelzweig et al.

Summary: Patients with major GI bleeding on oral anticoagulant treatment have a higher risk of stroke/systemic embolism, major bleeding, and mortality after discharge, with a significant proportion discontinuing their medication. Effective management strategies are needed for these high-risk patients.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Initiator Types and the Causal Question of the Prevalent New-User Design: A Simulation Study

Michael Webster-Clark et al.

Summary: The new-user design restricting to treatment initiators is preferred for studying drug comparative safety and effectiveness. This design reduces bias but sacrifices study size and external validity. Time-conditional propensity score matching is recommended to mitigate prevalent user bias.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients switched from vitamin K antagonists: A systematic review and meta-analysis

Maja Hellfritzsch et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Factors That Affect Time to Switch From Warfarin to a Direct Oral Anticoagulant After Change in the Reimbursement Criteria in Patients With Atrial Fibrillation

Susin Park et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry

Miney Paquette et al.

AMERICAN JOURNAL OF CARDIOLOGY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation

Sylvie Perreault et al.

PHARMACOTHERAPY (2020)

添加到收藏夹

Review Health Care Sciences & Services

Trends in anticoagulant prescribing: a review of local policies in English primary care

Katherine H. Ho et al.

BMC HEALTH SERVICES RESEARCH (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

John W. Stanifer et al.

CIRCULATION (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry

Christopher T. Sciria et al.

CLINICAL CARDIOLOGY (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Using the Case-Crossover Design to Assess Short-Term Risks of Bleeding and Arterial Thromboembolism After Switching Between Oral Anticoagulants in a Population-Based Cohort of Patients With Atrial Fibrillation

Maja Hellfritzsch et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges

Ashley Chen et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

添加到收藏夹

Article Medicine, General & Internal

A nurse-led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes

Jose Miguel Rivera-Caravaca et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

Jason G. Andrade et al.

CANADIAN JOURNAL OF CARDIOLOGY (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Real-world on-treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults

Michael Webster-Clark et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Impact of Hospitalization and Medication Switching on Post-discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation

Thanh Phuong Pham Nguyen et al.

PHARMACOTHERAPY (2020)

添加到收藏夹

Article Neurosciences

Managing Ischemic Stroke in Patients Already on Anticoagulation for Atrial Fibrillation: A Nationwide Practice Survey

Setareh Salehi Omran et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term vitamin K antagonist treatment to dabigatran

Eue-Keun Choi et al.

OPEN HEART (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Atrial fibrillation patients' experiences and perspectives of anticoagulation therapy changes

Shahrzad Salmasi et al.

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2020)

添加到收藏夹

Article Hematology

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Gilda Denise Zielinski et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry

Uwe Zeymer et al.

CARDIOLOGY AND THERAPY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study)

Dragos Vinereanu et al.

OPEN HEART (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries

P. P. Olimpieri et al.

IJC HEART & VASCULATURE (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis

Estella Davis et al.

PHARMACY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Hospitalization affects the anticoagulation patterns of patients with atrial fibrillation

Anastasios Kartas et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study

Anibal Garcia-Sempere et al.

PLOS ONE (2019)

添加到收藏夹

Article Hematology

Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study

Stefan H. Hohnloser et al.

THROMBOSIS AND HAEMOSTASIS (2019)

添加到收藏夹

Article Health Care Sciences & Services

Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin

Sreeram V. Ramagopalan et al.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Real-world adherence for direct oral anticoagulants in anewly diagnosed atrial fibrillation cohort: does the dosing interval matter?

Phuong N. Pham et al.

BMC CARDIOVASCULAR DISORDERS (2019)

添加到收藏夹

Article Medicine, General & Internal

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

Amol D. Dhamane et al.

CURRENT MEDICAL RESEARCH AND OPINION (2019)

添加到收藏夹

Article Hematology

Evaluating utilization patterns of oral anticoagulants in routine care

Chandrasekar Gopalakrishnan et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016

Matthew Alcusky et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)

Raffaele De Caterina et al.

BMC CARDIOVASCULAR DISORDERS (2019)

添加到收藏夹

Review Public, Environmental & Occupational Health

Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies

Antonios Douros et al.

DRUG SAFETY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Assessing patient preferences for switching from warfarin to direct oral anticoagulants

Jack N. Wright et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

The treatment pattern and adherence to direct oral anticoagulants in patients with atrial fibrillation aged over 65

Sola Han et al.

PLOS ONE (2019)

添加到收藏夹

Article Medicine, General & Internal

Reliability and validity of the Maltese version of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q)

Nicoletta Riva et al.

PATIENT PREFERENCE AND ADHERENCE (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Real-world persistence with direct oral anticoagulants (DOACs) in naive patients with non-valvular atrial fibrillation

Eliana Ferroni et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients

Annachiara Bellin et al.

PLOS ONE (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Management and outcomes of real-world use of non-vitamin-K oral anticoagulants (NOACs) in patients with atrial fibrillation: experience of a dedicated NOAC clinic

A. J. W. M. de Veer et al.

NETHERLANDS HEART JOURNAL (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States

Christine L. Baker et al.

ADVANCES IN THERAPY (2019)

添加到收藏夹

Article Medicine, General & Internal

Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK

Ana Ruigomez et al.

BMJ OPEN (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation

Naja Emborg Vinding et al.

EUROPACE (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study

Paolo Verdecchia et al.

JOURNAL OF CARDIOVASCULAR MEDICINE (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Safety and effectiveness of apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A regulatory postmarketing surveillance, the STANDARD study

Hiroshi Inoue et al.

JOURNAL OF ARRHYTHMIA (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study

Yukihiro Koretsune et al.

CARDIOLOGY AND THERAPY (2019)

添加到收藏夹

Article Hematology

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

Christine L. Baker et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation

Emil L. Fosbol et al.

EUROPACE (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases

Geric Maura et al.

PHARMACOTHERAPY (2018)

添加到收藏夹

Article Medicine, General & Internal

ESPACOMP Medication Adherence Reporting Guideline (EMERGE)

Sabina De Geest et al.

ANNALS OF INTERNAL MEDICINE (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy

Raffaele De Caterina et al.

ARCHIVES OF CARDIOVASCULAR DISEASES (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Initiation and continuation of oral anticoagulant prescriptions for stroke prevention in non-valvular atrial fibrillation: A cohort study in primary care in France

Shuk-Li Collings et al.

ARCHIVES OF CARDIOVASCULAR DISEASES (2018)

添加到收藏夹

Article Primary Health Care

Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction

Simon Schwill et al.

BMC FAMILY PRACTICE (2018)

添加到收藏夹

Review Economics

A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D

Ines Buchholz et al.

PHARMACOECONOMICS (2018)

添加到收藏夹

Article Public, Environmental & Occupational Health

Methodological challenges in assessment of current use of warfarin among patients with atrial fibrillation using dispensation data from administrative healthcare databases

Liliya Sinyavskaya et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)

添加到收藏夹

Article Medicine, General & Internal

Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation

Michael Benzimra et al.

PATIENT PREFERENCE AND ADHERENCE (2018)

添加到收藏夹

Article Medicine, General & Internal

Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy

Judith J. Stephenson et al.

PATIENT PREFERENCE AND ADHERENCE (2018)

添加到收藏夹

Article Medicine, General & Internal

A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study

Takanori Ikeda et al.

PATIENT PREFERENCE AND ADHERENCE (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Healthcare Utilization and Expenditures in Working-Age Adults with Atrial Fibrillation: The Effect of Switching from Warfarin to Non-Vitamin K Oral Anticoagulants

Xue Feng et al.

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)

添加到收藏夹

Article Medicine, General & Internal

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

Andrea C. Tricco et al.

ANNALS OF INTERNAL MEDICINE (2018)

添加到收藏夹

Article Critical Care Medicine

Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report

Gregory Y. H. Lip et al.

CHEST (2018)

添加到收藏夹

Article Medicine, General & Internal

Patient-reported treatment satisfaction with rivaroxaban in Japanese non-valvular atrial fibrillation patients: an observational study

Yukihiro Koretsune et al.

CURRENT MEDICAL RESEARCH AND OPINION (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Warfarin control in patients transitioning to warfarin after non-vitamin K oral anticoagulant (NOAC) therapy

Nijole Bernaitis et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Predictors of Major Bleeding Among Working-Age Adults with Atrial Fibrillation: Evaluating the Effects of Potential Drug-drug Interactions and Switching from Warfarin to Non-vitamin K Oral Anticoagulants

Xue Feng et al.

CARDIOVASCULAR DRUGS AND THERAPY (2018)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Stroke Prevention with Oral Anticoagulants: Summary of the Evidence and Efficacy Measures as an Aid to Treatment Choices

Jose Francisco Kerr Saraiva

CARDIOLOGY AND THERAPY (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation

Maja Hellfritzsch et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulant

Zachary D. Hale et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)

添加到收藏夹

Article Clinical Neurology

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation

Inmaculada Hernandez et al.

STROKE (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015

Lars J. Kjerpeseth et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation

Lindsay G. S. Bengtson et al.

JOURNAL OF CARDIOLOGY (2017)

添加到收藏夹

Article Neurosciences

Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention

Teruyuki Hirano et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation

Miney Paquette et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2

Menno V. Huisman et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy

Beenish S. Manzoor et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)

添加到收藏夹

Article Medicine, General & Internal

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis

Charles V. Pollack et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Public, Environmental & Occupational Health

Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study

Antonios Douros et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

添加到收藏夹

Article Public, Environmental & Occupational Health

Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study

Geric Maura et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

添加到收藏夹

Article Public, Environmental & Occupational Health

Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies

Tanja Mueller et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

添加到收藏夹

Article Medicine, General & Internal

Uptake of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation a prospective cohort study

Matylda Zimny et al.

SWISS MEDICAL WEEKLY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry

R. Pisters et al.

NETHERLANDS HEART JOURNAL (2017)

添加到收藏夹

Article Medicine, General & Internal

Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study

Yukihiro Koretsune et al.

PATIENT PREFERENCE AND ADHERENCE (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients

Morten Lamberts et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)

添加到收藏夹

Article Neurosciences

Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention

Teruyuki Hirano et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)

添加到收藏夹

Article Medicine, General & Internal

Medium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experience

Leon A. Simons et al.

CURRENT MEDICAL RESEARCH AND OPINION (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation

Todd A. Durham et al.

AMERICAN JOURNAL OF CARDIOLOGY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation

Faye L. Norby et al.

BMC CARDIOVASCULAR DISORDERS (2017)

添加到收藏夹

Article Medicine, Research & Experimental

The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey

Tatjana S. Potpara et al.

ADVANCES IN THERAPY (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Switching, Adverse Effects and Use of Over-the-Counter Analgesics among Users of Oral Anticoagulants: A Pharmacy-based Survey

Maja Hellfritzsch et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation

Tomas Forslund et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA2DS2-VASc and Time in Therapeutic Range

Pak-Hei Chan et al.

CANADIAN JOURNAL OF CARDIOLOGY (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy

Craig I. Coleman et al.

CLINICAL CARDIOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

The safety and persistence of non-vitamin-K-antagonist oral anticoagulants in atrial fibrillation patients treated in a well structured atrial fibrillation clinic

Faris Al-Khalili et al.

CURRENT MEDICAL RESEARCH AND OPINION (2016)

添加到收藏夹

Review Public, Environmental & Occupational Health

Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies

Emanuel Raschi et al.

DRUG SAFETY (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation

Yi-Hsin Chan et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

添加到收藏夹

Article Hematology

Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC A cohort study

Carlos Martinez et al.

THROMBOSIS AND HAEMOSTASIS (2016)

添加到收藏夹

Article Multidisciplinary Sciences

The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation

Michelle Sholzberg et al.

PLOS ONE (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Patient-Reported Treatment Satisfaction with Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study

Olivier Hanon et al.

PLOS ONE (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

Christopher B. Granger et al.

AMERICAN HEART JOURNAL (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Drug persistence with rivaroxaban therapy in atrial fibrillation patients-results from the Dresden non-interventional oral anticoagulation registry

Jan Beyer-Westendorf et al.

EUROPACE (2015)

添加到收藏夹

Article Medicine, General & Internal

Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level: The Swiss Therapy in Atrial Fibrillation for the Regulation of Coagulation (STAR) Study

Rolf P. Engelberger et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)

添加到收藏夹

Article Medicine, General & Internal

Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic

S. I. Lee et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2015)

添加到收藏夹

Article Hematology

Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants

Franziska Michalski et al.

THROMBOSIS AND HAEMOSTASIS (2015)

添加到收藏夹

Article Hematology

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study

Kim Bouillon et al.

LANCET HAEMATOLOGY (2015)

添加到收藏夹

Article Medicine, General & Internal

Bleeding Rates in Veterans Affairs Patients with Atrial Fibrillation Who Switch from Warfarin to Dabigatran

Mary S. Vaughan Sarrazin et al.

AMERICAN JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Medicine, General & Internal

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study

Torben Bjerregaard Larsen et al.

AMERICAN JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Medicine, General & Internal

Patterns of Initiation of Oral Anticoagulants in Patients with Atrial Fibrillation-Quality and Cost Implications

Nihar R. Desai et al.

AMERICAN JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Medicine, General & Internal

Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation

Torben Bjerregaard Larsen et al.

AMERICAN JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Medicine, General & Internal

Myocardial Ischemic Events in 'Real World' Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin

Torben Bjerregaard Larsen et al.

AMERICAN JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Medicine, General & Internal

Characteristics of patients with non-valvular atrial fibrillation using dabigatran or warfarin in the US

Nils Schoof et al.

CURRENT MEDICAL RESEARCH AND OPINION (2014)

添加到收藏夹

Article Hematology

Dynamics of vitamin K antagonist and new oral anticoagulants use in atrial fibrillation: a Danish drug utilization study

A. Pottegard et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey

Hazem F. Elewa et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

A single centre experience of the efficacy and safety of dabigatran etexilate used for stroke prevention in atrial fibrillation

Lok Bin Yap et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effect of Dabigatran on Referrals to and Switching From Warfarin in Two Academic Anticoagulation Management Services

Julie K. Atay et al.

AMERICAN JOURNAL OF CARDIOLOGY (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

End of Study Transition From Study Drug to Open-Label Vitamin K Antagonist Therapy: The ROCKET AF Experience

Kenneth W. Mahaffey et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)

添加到收藏夹

Article Medicine, General & Internal

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Robert P. Giugliano et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

添加到收藏夹

Article Medicine, General & Internal

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

Rikke Sorensen et al.

BMJ OPEN (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation

Benjamin A. Steinberg et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)

添加到收藏夹

Article Pharmacology & Pharmacy

A NEW TAXONOMY FOR DESCRIBING AND DEFINING ADHERENCE TO MEDICATIONS

B. Vrijens et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)

添加到收藏夹

Review Pharmacology & Pharmacy

Renal Profiles of Anticoagulants

Sebastian Harder

JOURNAL OF CLINICAL PHARMACOLOGY (2012)

添加到收藏夹

Article Medicine, General & Internal

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Article Medicine, General & Internal

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Letter Medicine, General & Internal

Newly Identified Events in the RE-LY Trial

Stuart J. Connolly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

添加到收藏夹

Article Health Care Sciences & Services

Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q©)

M. H. Prins et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2009)

添加到收藏夹

Article Health Care Sciences & Services

Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q©)

Martin H. Prins et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2009)

添加到收藏夹

Article Medicine, General & Internal

Dabigatran versus Warfarin in Patients with Atrial Fibrillation.

Stuart J. Connolly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.